Key facts
- It has raised $13.2M; the latest was Later Stage VC in Aug 2025.
- Notable investors include EIT Food, StartLife, Oost NL, Bridford Group, Elaine Groenestein — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Hudson River Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Hudson River Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hudson River Biotechnology
Developer of an agricultural biotechnology company intended to create new traits and varieties. The company offers advanced gene editing capabilities, accelerated breeding processes, and a scalable research infrastructure, enabling agricultural producers and consumer goods companies to respond to climate stress, increase productivity, and meet changing market demands.
- Sector
- Materials and Resources
- HQ
- Wageningen, Netherlands
- Founded
- 2015
- Employees
- 26
- Website
- hudsonriver.bio/
- Ownership
- Privately Held (backing)
Hudson River Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hudson River Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hudson River Biotechnology in its N-PORT filings yet. We sweep new filings monthly.